# MRI-guided thrOmbolysis for Stroke bEyond Time Window by TNK

> **NCT04752631** · PHASE4 · COMPLETED · sponsor: **General Hospital of Shenyang Military Region** · enrollment: 80 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Tenecteplase

## Key facts

- **NCT ID:** NCT04752631
- **Lead sponsor:** General Hospital of Shenyang Military Region
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-09
- **Primary completion:** 2022-07-24
- **Final completion:** 2022-07-24
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2022-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04752631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04752631, "MRI-guided thrOmbolysis for Stroke bEyond Time Window by TNK". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04752631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*